| Drug Type Chemical drugs | 
| Synonyms- | 
| Target | 
| Action inhibitors | 
| Mechanism PRKDC inhibitors(DNA-dependent protein kinase inhibitors) | 
| Therapeutic Areas | 
| Active Indication | 
| Inactive Indication- | 
| Originator Organization | 
| Active Organization | 
| Inactive Organization- | 
| License Organization- | 
| Drug Highest PhasePreclinical | 
| First Approval Date- | 
| Regulation- | 
| Indication | Highest Phase | Country/Location | Organization | Date | 
|---|---|---|---|---|
| Squamous Cell Carcinoma of Head and Neck | Preclinical | New Zealand  | 01 Jan 2024 | 





